Novo Nordisk A/S (NVO)
44.28
-0.46
(-1.03%)
USD |
NYSE |
May 18, 16:00
44.15
-0.13
(-0.29%)
Pre-Market: 06:35
Novo Nordisk Cash and Short Term Investments (Quarterly) : 3.335B for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AstraZeneca PLC | 7.675B |
| GSK Plc | 4.540B |
| Johnson & Johnson | 22.05B |
| Eli Lilly & Co. | 5.282B |
| Lexicon Pharmaceuticals, Inc. | 170.66M |